Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Change in Accured Expenses (2020 - 2022)

Historic Change in Accured Expenses for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q4 2022 value amounting to $1.5 million.

  • Atea Pharmaceuticals' Change in Accured Expenses fell 8597.98% to $1.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$37.6 million, marking a year-over-year decrease of 18574.65%. This contributed to the annual value of -$13.4 million for FY2024, which is 20600.27% down from last year.
  • Per Atea Pharmaceuticals' latest filing, its Change in Accured Expenses stood at $1.5 million for Q4 2022, which was down 8597.98% from $2.5 million recorded in Q3 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Change in Accured Expenses peaked at $17.0 million during Q2 2021, and registered a low of -$28.0 million during Q1 2022.
  • Its 3-year average for Change in Accured Expenses is $1.6 million, with a median of $2.8 million in 2020.
  • In the last 5 years, Atea Pharmaceuticals' Change in Accured Expenses skyrocketed by 188652.29% in 2021 and then crashed by 52266.14% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Change in Accured Expenses (Quarter) stood at $8.2 million in 2020, then rose by 29.6% to $10.6 million in 2021, then crashed by 85.98% to $1.5 million in 2022.
  • Its Change in Accured Expenses stands at $1.5 million for Q4 2022, versus $2.5 million for Q3 2022 and -$13.6 million for Q2 2022.